Search Results

Dinaciclib 50mg  | ≥99%

CSNpharm

Dinaciclib is a potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively.

More Information Supplier Page

Dinaciclib 1mg  | ≥99%

CSNpharm

Dinaciclib is a potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively.

More Information Supplier Page

Ligustrazine HCl 10mg  | ≥99%

CSNpharm

Ligustrazine HCl is a natural product isolated and purified from the rhizomes of Ligusticum chuanxiong Hort. with protective effect on the vascular endothelium undergoing CPB and homocysteine-injured ECV304 cells.

More Information Supplier Page

Ligustrazine HCl 5mg  | ≥99%

CSNpharm

Ligustrazine HCl is a natural product isolated and purified from the rhizomes of Ligusticum chuanxiong Hort. with protective effect on the vascular endothelium undergoing CPB and homocysteine-injured ECV304 cells.

More Information Supplier Page

ICI-118551 HCl 10mg  | ≥99%

CSNpharm

ICI 118551 HCl is a selective and inverse β2 adrenergic receptor antagonist with Ki values of 1.2, 120 and 257nM for β2, β1 and β3 receptors, respectively.

More Information Supplier Page

ICI-118551 HCl 5mg  | ≥99%

CSNpharm

ICI 118551 HCl is a selective and inverse β2 adrenergic receptor antagonist with Ki values of 1.2, 120 and 257nM for β2, β1 and β3 receptors, respectively.

More Information Supplier Page

ICI-118551 HCl 50mg  | ≥99%

CSNpharm

ICI 118551 HCl is a selective and inverse β2 adrenergic receptor antagonist with Ki values of 1.2, 120 and 257nM for β2, β1 and β3 receptors, respectively.

More Information Supplier Page

ICI-118551 HCl 100mg  | ≥99%

CSNpharm

ICI 118551 HCl is a selective and inverse β2 adrenergic receptor antagonist with Ki values of 1.2, 120 and 257nM for β2, β1 and β3 receptors, respectively.

More Information Supplier Page

K858 25mg  | ≥99%

CSNpharm

K858 is a selective and ATP-uncompetitive mitotic kinesin Eg5 inhibitor with IC50 value of 1.3 μM.

More Information Supplier Page

K858 100mg  | ≥99%

CSNpharm

K858 is a selective and ATP-uncompetitive mitotic kinesin Eg5 inhibitor with IC50 value of 1.3 μM.

More Information Supplier Page